Fuji Pharma Invests US$50 Million In Alvotech

 
• By Grace Montgomery

Japanese firm Fuji Pharma has acquired a minority stake in Alvotech for around US$50 million, shortly after the firms entered an exclusive agreement to develop and supply the latter’s biosimilars portfolio in Japan.

Melon slices
Fuji Pharma takes a slice of Alvotech for US$50 million • Source: Shutterstock

More from Biosimilars

More from Products